Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 18 studies | 34% ± 14% | |
endothelial cell | 17 studies | 38% ± 18% | |
basal cell | 17 studies | 37% ± 13% | |
smooth muscle cell | 16 studies | 29% ± 10% | |
epithelial cell | 16 studies | 36% ± 18% | |
fibroblast | 16 studies | 25% ± 10% | |
endothelial cell of lymphatic vessel | 14 studies | 42% ± 11% | |
secretory cell | 11 studies | 39% ± 12% | |
capillary endothelial cell | 11 studies | 34% ± 16% | |
ciliated cell | 11 studies | 32% ± 14% | |
club cell | 9 studies | 30% ± 11% | |
type I pneumocyte | 8 studies | 39% ± 16% | |
connective tissue cell | 8 studies | 25% ± 5% | |
oligodendrocyte precursor cell | 7 studies | 33% ± 8% | |
type II pneumocyte | 6 studies | 26% ± 8% | |
respiratory goblet cell | 6 studies | 29% ± 13% | |
kidney loop of Henle epithelial cell | 5 studies | 23% ± 2% | |
abnormal cell | 5 studies | 44% ± 10% | |
conventional dendritic cell | 5 studies | 24% ± 4% | |
macrophage | 4 studies | 23% ± 8% | |
glomerular endothelial cell | 4 studies | 49% ± 15% | |
myofibroblast cell | 4 studies | 44% ± 11% | |
endothelial cell of artery | 4 studies | 21% ± 6% | |
brush cell | 4 studies | 29% ± 13% | |
microglial cell | 4 studies | 30% ± 15% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 30% ± 11% | |
keratinocyte | 4 studies | 34% ± 16% | |
duct epithelial cell | 3 studies | 25% ± 2% | |
hillock cell | 3 studies | 30% ± 13% | |
neural crest cell | 3 studies | 34% ± 10% | |
vein endothelial cell | 3 studies | 30% ± 18% | |
hepatocyte | 3 studies | 45% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 6879.54 | 245 / 245 | 97% | 133.86 | 488 / 502 |
skin | 100% | 13738.38 | 1806 / 1809 | 95% | 326.22 | 449 / 472 |
esophagus | 99% | 6461.35 | 1436 / 1445 | 94% | 320.96 | 172 / 183 |
thymus | 99% | 4715.93 | 647 / 653 | 93% | 270.09 | 560 / 605 |
breast | 98% | 6945.68 | 451 / 459 | 91% | 398.67 | 1013 / 1118 |
pancreas | 97% | 2810.38 | 318 / 328 | 88% | 120.52 | 156 / 178 |
lung | 99% | 5972.50 | 570 / 578 | 85% | 174.64 | 984 / 1155 |
intestine | 88% | 2417.24 | 854 / 966 | 95% | 142.44 | 499 / 527 |
bladder | 95% | 2807.14 | 20 / 21 | 82% | 160.87 | 415 / 504 |
stomach | 82% | 2590.06 | 294 / 359 | 93% | 150.84 | 265 / 286 |
kidney | 88% | 3105.38 | 78 / 89 | 82% | 336.20 | 742 / 901 |
adrenal gland | 98% | 3539.08 | 254 / 258 | 66% | 79.30 | 152 / 230 |
liver | 96% | 4729.73 | 216 / 226 | 51% | 76.13 | 206 / 406 |
brain | 64% | 1425.82 | 1686 / 2642 | 56% | 62.11 | 397 / 705 |
uterus | 65% | 1901.72 | 110 / 170 | 45% | 59.42 | 208 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 419.41 | 1 / 1 |
blood vessel | 100% | 6694.72 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 4156.02 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 223.23 | 78 / 80 |
adipose | 95% | 6226.79 | 1148 / 1204 | 0% | 0 | 0 / 0 |
spleen | 82% | 2161.55 | 198 / 241 | 0% | 0 | 0 / 0 |
ovary | 18% | 321.49 | 33 / 180 | 63% | 90.58 | 269 / 430 |
tonsil | 0% | 0 | 0 / 0 | 47% | 65.20 | 21 / 45 |
lymph node | 0% | 0 | 0 / 0 | 7% | 3.73 | 2 / 29 |
peripheral blood | 5% | 91.17 | 43 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 13.83 | 7 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010971 | Biological process | positive regulation of G2/M transition of mitotic cell cycle |
GO_0044321 | Biological process | response to leptin |
GO_0045444 | Biological process | fat cell differentiation |
GO_0070141 | Biological process | response to UV-A |
GO_0033598 | Biological process | mammary gland epithelial cell proliferation |
GO_0000079 | Biological process | regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0006974 | Biological process | DNA damage response |
GO_0045737 | Biological process | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0051301 | Biological process | cell division |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0060749 | Biological process | mammary gland alveolus development |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_0030857 | Biological process | negative regulation of epithelial cell differentiation |
GO_0030182 | Biological process | neuron differentiation |
GO_0097421 | Biological process | liver regeneration |
GO_0033601 | Biological process | positive regulation of mammary gland epithelial cell proliferation |
GO_0007595 | Biological process | lactation |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0031571 | Biological process | mitotic G1 DNA damage checkpoint signaling |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0000320 | Biological process | re-entry into mitotic cell cycle |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0097131 | Cellular component | cyclin D1-CDK6 complex |
GO_0097128 | Cellular component | cyclin D1-CDK4 complex |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0000307 | Cellular component | cyclin-dependent protein kinase holoenzyme complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0061575 | Molecular function | cyclin-dependent protein serine/threonine kinase activator activity |
GO_0070064 | Molecular function | proline-rich region binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0016538 | Molecular function | cyclin-dependent protein serine/threonine kinase regulator activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | CCND1 |
Protein name | Cyclin D1 G1/S-specific cyclin-D1 G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene) |
Synonyms | hCG_2016647 PRAD1 BCL1 |
Description | FUNCTION: Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition . Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase . Hypophosphorylates RB1 in early G(1) phase . Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals . Also a substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity . Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex . Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner . . |
Accessions | P24385 ENST00000536559.1 Q6FI00 F5H437 Q5MGB2 ENST00000227507.3 |